Craniopharyngioma in childhood (Q36647151)

15 August 2017

1 reference

title

Craniopharyngioma in childhood (English)

1 reference

15 August 2017

1 reference

Joshua A May

1

1 reference

15 August 2017

Mark D Krieger

series ordinal

2

1 reference

15 August 2017

Ira Bowen

series ordinal

3

1 reference

15 August 2017

Mitchell E Geffner

series ordinal

4

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

published in

Advances in pediatrics

1 reference

15 August 2017

volume

53

1 reference

15 August 2017

page(s)

183-209

1 reference

A history of the treatment of craniopharyngiomas

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngiomas in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Management of craniopharyngioma in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

A critical review of personal experiences with craniopharyngioma: clinical history, surgical technique and operative results. 1983.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Population-based epidemiologic data on brain tumors in German children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto Prefecture, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Incidence of childhood brain tumors in Syria (1993-2002)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

The descriptive epidemiology of craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Pathology of craniopharyngiomas: clinical import of pathological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngiomas in two consanguineous siblings: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma in a mother and daughter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Multiple chromosomal abnormalities in a case of craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma: endocrine abnormalities at presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma: presentation and endocrine sequelae in 36 children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

The syndrome of inappropriate secretion of antidiuretic hormone: an unusual presentation for childhood craniopharyngioma: report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Three cases of craniopharyngioma showing optic tract hypersignal on MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Rathke's cleft cyst in two girls with precocious puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Malignant astrocytoma following radiotherapy for craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Individualized treatment of pediatric craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma: treatment in the CT and MR imaging era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Surgical management of craniopharyngiomas. A review of 74 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

The role of radiation therapy in the treatment of craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Radiation therapy in the management of pediatric craniopharyngiomas--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Repositioning accuracy with the Laitinen frame for fractionated stereotactic radiation therapy in adult and pediatric brain tumors: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Fractionated stereotactic radiotherapy for craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Tolerance of cranial nerves of the cavernous sinus to radiosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Advances in radiation therapy for craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Outcomes and failure patterns in childhood craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Hypopituitarism in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Growth without growth hormone: evidence for a potent circulating human growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

The growth without growth hormone syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma: The Role of Insulin in Promoting Postoperative Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Growth before and during growth hormone treatment in children operated for craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

CRANIOPHARYNGIOMA RECURRENCE AND GROWTH HORMONE THERAPY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngiomas of childhood: the CHLA experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

The endocrine outcome after surgical removal of craniopharyngiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Defect in epinephrine production in children with craniopharyngioma: functional or organic origin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Features of the metabolic syndrome after childhood craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Serum leptin levels following hypothalamic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Ectopic recurrences of craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Malignant glioma as a secondary malignant neoplasm after radiation therapy for craniopharyngioma: report of a case and review of reported cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Neurological and behavioral sequelae following different approaches to craniopharyngioma. Long-term follow-up review and therapeutic guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Neurobehavioral outcome in pediatric craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

Fractionated proton radiation therapy of cranial and intracranial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YAPD.2006.04.013

1 reference

15 August 2017

1 reference